Skip to main content
Top

Chinese Journal of Cancer Research

Issue 3/2009

Content (12 Articles)

Cellular and Molecular Biology

Effect on proliferation and erythroid differentiation of K562 Cells by IER3IP1-knockdown

Yan Lei, Yan Zhang, Ting-mei Chen, Yong-qiang Wang

Carcinogenesis

GSTM1 and XRCC3 polymorphisms: Effects on levels of aflatoxin B1-DNA adducts

Xi-dai Long, Yun Ma, Zhou-lin Deng

Detection in situ of E-cadherin, β-catenin, TCF4 and CDX2 in various gastric diseases

Xiu-wen Yu, Qian Xu, Yue-hua Gong, Nan-nan Dong, Yuan Yuan

Apoptosis of human pancreatic carcinoma cells induced by all-trans retinoic acid and interferon

Xiao-hua Wang, Yuan-qin Yin, Ping Ma, Cheng-guang Sui, Fan-dong Meng, Jiang You-hong

Breast Cancer

Expression of ΔDNMT3B variants and its association with estrogen/progestogen receptor status in breast cancer

Ning-hong Liu, Lu Yang, Ming-lei Zhuo, Jie Wang, Shu-hang Wang, Jun Zhao, Hua Bai

Neurologic Cancer

Expressions of GSK-3beta, Beta-catenin and PPAR-gamma in medulloblastoma

Xiong Zhang, Lu Si, Yu Li, Can Mi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine